VOLUME 9 NUMBER 4 • NOVEMBER 2012
157
SA JOURNAL OF DIABETES & VASCULAR DISEASE
REVIEW
Europe, presented these findings first in a Symposium of DDD in
Athens, 2009. Anna Muntingh, MSc Trimbos Instituut, assisted
with the layout of Fig. 1. Prof Dr Frank Snoek, PhD, VU University
Amsterdam, assisted with the layout of Table 2.
Funding
This research received no specific grant from any funding agency in
the public, commercial or not-for-profit sectors.
Conflict of interest
In the last three years, Prof Dr van der Feltz-Cornelis has received
royalties for books written on the topic of psychiatry. Trimbos
Instituut received a grant from Eli Lilly for her writing a systematic
review and presenting a lecture on diabetes and depression.
References
1.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid
depression in adults with diabetes.
Diabetes Care
2001;
24
:1069–78.
2.
Katon WJ. Clinical and health services relationships between major
depression, depressive symptoms, and general medical illness.
Biol Psychiatry
2003;
54
:216–26.
3.
Ali S, Stone MA, Peters JL
et al.
The prevalence of co-morbid depression in
adults with Type 2 diabetes: a systematic review and meta-analysis.
Diabet Med
2006;
23
:1165–73.
4.
Ludman EJ, Katon W, Russo J
et al
.
Depression and diabetes symptom burden.
Gen Hosp Psychiatry
2004;
26
:430–6.
5.
Lustman PJ, Anderson RJ, Freedland KE
et al
.
Depression and poor
glycemic control: a meta analytic review of the literature.
Diabetes Care
2000;23:934–42.
6.
de Groot M, Anderson R, Freedland KE
et al.
Association of depression and
diabetes complications: a meta-analysis.
Psychosom Med
2001;
63
:619–30.
7.
DiMatteo MR, Lepper HS and Croghan TW. Depression is a risk factor for
noncompliance with medical treatment: meta-analysis of the effects of anxiety
and depression on patient adherence.
Arch Intern Med
2000;
160
:2101–17.
8.
Katon W, Van der Feltz-Cornelis CM. Treatment of depression in patients with
diabetes: Efficacy, effectiveness and maintenance trials, and new service models.
In: Katon W, Maj M, Sartorius N (eds.). Depression and Diabetes. London: Wiley,
2010;
81
–108.
9.
Von Korff M, Katon W, Lin EH
et al
.
Work disability among individuals with
diabetes.
Diabetes Care
2005;
28
:1326–32.
10.
Schram, Baan CA, Pouwer F. Depression and quality of life in patients with
diabetes: a systematic review from theEuropean Depression in Diabetes (EDID)
Research Consortium.
Curr Diabetes Rev
2009;
5
:112–19.
11.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased
health care use and expenditures in individuals with diabetes.
Diabetes Care
2002;
25
:464–70.
12.
Cohen Y, Vice President GAMIAN EUROPE. The Perspective of Service Users and
families managing Diabetes and Depression. Presentation in collaboration with
DDD at the World Federation of Mental Health Symposium on the International
Programme on the comorbidity of Mental and Physical disorders. 6 September
2009,
Athens, Greece.
13.
Take Control Peaks and Valleys. Innovations and Insights in Diabetes Management.
South Asian Regional Conference. 23–26 March 2011, Hong Kong.
14.
Lustman PJ, Clause RE. Non psychiatric physicians identification and treatment
of depression in diabetes.
Compr Psychiatry
1987;
28
:22–7.
15.
Nicholson TR, Taylor JP, Gosden C
et al.
National guidelines for psychological care
in diabetes: how mindful have we been?
Diabet Med
2009;
26
:447–50.
16.
Valenstein M, Vijan S, Zeber JE
et al
.
The Cost-Utility of Screening for Depression
in Primary Care.
Ann Intern Med
2001;
134
:345–60.
17.
Gilbody S, Sheldon T, House A. Screening and case-finding instruments for
depression: a meta-analysis.
CMAJ
2008;
178
:997–1003.
18.
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Arlington:
American Psychiatric Association, 1994.
19.
Van der Feltz-Cornelis CM, Nuijen J, Stoop C
et al
.
Effect of interventions for
Major Depressive Disorder and significant depressive symptoms in patients with
Diabetes Mellitus: a systematic review and meta analysis.
Gen Hosp Psychiatry
2010;
32
:380–95.
20.
Gulseren L, Gulseren S, Hekimsoy Z, Mete L. Comparison of fluoxetine and
paroxetine in type II diabetes mellitus patients. Arch Med Res 2004;
36
:159-65.
21.
Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in
diabetes.
Diabetes Care
2000;
23
:618–23.
22.
Paile-Hyvinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status
in mildly depressed women with type 2 diabetes treated with paroxetine: A
singleblind randomised placebo controlled trial.
BMC Fam Pract
2003;
4
:1–6.
23.
Lustman PJ, Clouse RE, Nix BD
et al
.
Sertraline for prevention of depression
recurrence in diabetes mellitus.
Arch Gen Psychiatry
2006;
63
:521–9.
24.
Echeverry D, Duran P, Bonds C
et al.
The effect of pharmacologic treatment
of depression on A1C and quality of life in low income Hispanics and African
Americans with diabetes: a randomized, double blind, placebo controlled trial.
Diabetes Care
2009;
32
:2156–60.
25.
Lustman PJ, Clouse RE, Griffith LS
et al
.
Screening for depression in diabetes using
the Beck Depression Inventory.
Psychosom Med
1997;
59
:24–31.
26.
McHale M, Hendrikz J, Dann F, Kenardy J. Screening for depression in patients
with diabetes mellitus.
Psychosom Med
2008;
70
:869–74.
27.
Van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR
et al
.
Validation of the
PHQ-9 as a screening instrument for depression in diabetes patients in specialized
outpatient clinics.
BMC Health Serv Res
2010;
12
:235.
28.
Kroenke K, Spitzer RL, Williams JB, Löwe B. The Patient Health Questionnaire
Somatic, Anxiety, and Depressive Symptom Scales: a systematic review.
Gen Hosp
Psychiatry
2010;
32
:345–59.
29.
Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH
et al
.
Limited effect of screening
for depression with written feedback in outpatients with diabetes mellitus: a
randomised controlled trial.
Diabetologia
2011;
54
:741–8.
30.
Katon W, Von Korff M, Lin E
et al
.
The Pathways Study: A randomized trial of
collaborative care in patients with diabetes and depression.
Arch Gen Psychiatry
2004;
61
:1042–9.
31.
Steenbergen-Weijenburg KM, Puffelen AL, van Horn EK
et al
.
More co-morbid
depression in patients with Type 2 diabetes with multiple complications. An
observational study at a specialized outpatient clinic.
Diabet Med
2011;
28
:86–9.
32.
Katon W, Van der Feltz-Cornelis CM. Treatment of depression in patients with
diabetes: Efficacy, effectiveness and maintenance trials, and new service models.
In: Katon W, Maj M, Sartorius N. (eds.). Depression and Diabetes. London: Wiley,
2010;81–108.
33.
Meeuwissen JAC, Holleman GJM, de Jong FJ
et al
.
Screening and guided self-help
intervention for anxiety and depression in patients with type 2 diabetes: A new
role for diabetes nurses in primary care?
Eur Diabetes Nursing
2011;
8
:47–52.
1...,5,6,7,8,9,10,11,12,13,14 16,17,18,19,20,21,22,23,24,25,...52